Skip to content
Governance Register

← US public companies

Rein Therapeutics, Inc.

SEC CIK 1420565 · RNTX · last insider filing 2026-05-28

Directors (from insider filings)

NameCapacity as filedFilings
VON Rickenbach Josef H Director filed 2019 - 2026
Windsor James Brian Director · See Remarks filed 2023 - 2026
Musso Alan A Director filed 2023 - 2025
Aivado Manuel Director · See Remarks filed 2017 - 2025
Ambros Reinhard J. Director filed 2017 - 2025
Fairey William Director filed 2023 - 2025
Mckee William Director filed 2019 - 2022
Sigal Nolan Howard Director filed 2019 - 2022
Bailey Jeffrey Allen Director filed 2018 - 2022
Morrison Jodie Pope Director filed 2017 - 2022
Satter Muneer A Director · See Remarks filed 2017 - 2021
Mcarthur John H Director filed 2017 - 2019
Kapnick Scott Director filed 2017 - 2018
Shanafelt Armen Director filed 2017 - 2018
Winder Caleb Maxfield Director filed 2017 - 2018
Yanchik Joseph A., III Director · See Remarks filed 2017 - 2017
Gallagher Brian M. Jr. Director filed 2017 - 2017

Officers (from insider filings)

NameTitle as filedFilings
Cunningham Timothy M. See Remarks filed 2024 - 2024
Garner Charles Senior Vice President, Finance filed 2024 - 2024
Drexler Susan L. See Remarks filed 2022 - 2022
Vukovic Vojo SVP, Chief Medical Officer filed 2018 - 2022
Annis Allen See Remarks filed 2017 - 2022
Wanstall Rick VP, Finance and Operations filed 2019 - 2022
Gregory Kathryn SVP, Chief Business Officer filed 2019 - 2020
Dougherty Donald SVP & Chief Financial Officer filed 2017 - 2019
Longenecker John P PHD President and CEO filed 2018 - 2018
Nelson Kira See Remarks filed 2017 - 2017

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.